Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | ‘The World OTC Pharmaceutical Market will reach $92.9bn in 2015’ predicts new Visiongain reportBy: Visiongain 
vg The growth in the world OTC pharma market will mainly be driven by double-digit growth rates exhibited in the emerging markets. Indonesia is expected to be the fastest growing OTC pharmaceutical market over the forecast period. Major drivers of growth in the emerging markets include increasing consumer wealth and sustained population growth, which are particularly pronounced in Indonesia. On the global level, societal shifts towards people’s engagement in their own health should increase the use of OTC drugs over the forecast period. The emergence of the internet and social media platforms have enabled patients to be better informed to self-medicate. Not only should this benefit public health by reducing the under treatment of disease, but stakeholders such as healthcare payers and healthcare systems would financially benefit if patients pay out of their own pockets for OTC drugs. Amy To, pharmaceutical and medical devices analyst at visiongain explains: “In 2014, there has been further consolidation in the Pharmaceutical OTC market in what has been a transformative year for the industry. Significant developments include Bayer’s acquisition of Merck’s consumer care business and GSK and Novartis’ joint venture forming the GSK Consumer Health Care business. GSK Consumer Healthcare and Bayer have thus overtaken the global consumer healthcare giant Johnson & Johnson to become the 1st and 2nd largest OTC pharmaceutical companies in the world, respectively. The frenetic pace of M&A activity suggests that some companies believe consumer healthcare, including OTC medicines, will play a big role in their growth strategies. At the same time, some big pharma companies are abandoning OTC and therefore it really is an all-or-nothing game in this market.” Visiongain’s brand new 245 page report provides revenue forecasts to 2025 for the global OTC pharmaceutical market, its submarkets by medicine category and leading regional markets. It forecasts sales in the US, Japan, Europe (EU5: Germany, France, Italy, Spain, UK), China, India, Russia, Brazil, Turkey, Mexico, Indonesia and the Rest of the World. It also profiles the 10 leading OTC pharmaceutical companies, including their total and OTC division financial performance, revenue forecast, product portfolio and recent M&A activity. It also includes 2 interviews with industry experts regarding the current developments in the OTC pharmaceutical market. World OTC Pharmaceuticals Market Forecast 2015-2025: Prospects for Leading Companies adds to visiongain’s range of analytical reports on industries and markets in healthcare. For further information about World OTC Pharmaceuticals Market Forecast 2015-2025: Prospects for Leading Companies please visit https://www.visiongain.com/ For an executive summary please contact: Email: Sara Peerun on sara.peerun@ Tel: +44 (0) 20 7336 6100 Notes for Editors If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@ About visiongain Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. From its head office in London, UK, visiongain produces a range of newsletters, business reports and e-zines covering current affairs and market trends in the Energy, Telecoms, Pharmaceutical, Defence, and Materials sectors. Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first portofcall for the business professional who needs independent, high quality, original analyses to inform their strategic decisions. End
|
| |||||||||||||||||||||||||||||||||||||||||||||||
